ASCP Statement on the Elimination of the Clozapine REMS

As of February 24, 2025, the FDA no longer expects prescribers, patients and pharmacists to participate in the risk evaluation and mitigation strategies (REMS) program for clozapine.   This means pharmacies can dispense clozapine without knowledge of the patients...

The Journal of Clinical Psychiatry Call For Papers

CALL FOR PAPERSThe Journal of Clinical Psychiatry, official journal of the ASCP, wants your article submissions! What kind of papers is JCP looking for?Systematic reviews and meta-analyses focusing on current, clinically relevant topics in psychiatryNovel methods...